IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
175 hedge funds and large institutions have $1.97B invested in IVERIC bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 66 increasing their positions, 43 reducing their positions, and 14 closing their positions.
856% more call options, than puts
Call options by funds: $15.6M | Put options by funds: $1.63M
186% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 14
53% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 43
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
19% more capital invested
Capital invested by funds: $1.65B → $1.97B (+$320M)
17% more funds holding
Funds holding: 149 → 175 (+26)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$46.8M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$24.6M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$21.3M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$17.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$34M |
| 2 |
PA
Perceptive Advisors
New York
|
-$16.3M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$10.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$10.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.8M |
ISEE Hedge Fund Activity: Q4 2021 in Review
175 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2021, worth a combined $1.97B — up 19% from $1.65B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ISEE positions and 14 closed out — a net gain of 26 holders — while 66 added to existing stakes and 43 trimmed.
The largest buyer was Avidity Partners Management, adding an estimated $46.8M. The largest seller was Invesco, cutting an estimated $34M.
- 175 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2021, up from 149 in Q3 2021.
- Funds reported $1.97B of IVERIC bio, Inc. Common Stock stock for Q4 2021, up 19% quarter-over-quarter.
- 40 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2021 and 14 closed out, a net change of +26 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q4 2021 was Avidity Partners Management, an estimated $46.8M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q4 2021 was Invesco, an estimated $34M sold.
Based on aggregated 13F filings for Q4 2021.